This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Apr 14;41(15):1521-1522.

doi: 10.1093/eurheartj/ehaa078.

Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting

Patrick R Lawler^{1

2

3}, Robert S Rosenson⁴, Dennis T Ko^{3

5}

Affiliations

Affiliations

¹ Peter Munk Cardiac Centre, University Health Network, 200 Elizabeth St, Toronto, Ontario M5G2C4, Canada.
² Ted Rogers Centre for Heart Research, 661 University Avenue, 14th Floor, Toronto, Ontario M5G 1M1, Canada.
³ University of Toronto, 27 King's College Cir, Toronto, Ontario M5S 1K1, Canada.
⁴ Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
⁵ ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.

PMID: 32154871
DOI: 10.1093/eurheartj/ehaa078

Comment

Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting

Patrick R Lawler et al. Eur Heart J. 2020.

. 2020 Apr 14;41(15):1521-1522.

doi: 10.1093/eurheartj/ehaa078.

Authors

Patrick R Lawler^{1

2

3}, Robert S Rosenson⁴, Dennis T Ko^{3

5}

Affiliations

¹ Peter Munk Cardiac Centre, University Health Network, 200 Elizabeth St, Toronto, Ontario M5G2C4, Canada.
² Ted Rogers Centre for Heart Research, 661 University Avenue, 14th Floor, Toronto, Ontario M5G 1M1, Canada.
³ University of Toronto, 27 King's College Cir, Toronto, Ontario M5S 1K1, Canada.
⁴ Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
⁵ ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.

PMID: 32154871
DOI: 10.1093/eurheartj/ehaa078

No abstract available

PubMed Disclaimer

Comment on

Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.
Lawler PR, Kotrri G, Koh M, Goodman SG, Farkouh ME, Lee DS, Austin PC, Udell JA, Ko DT. Lawler PR, et al. Eur Heart J. 2020 Jan 1;41(1):86-94. doi: 10.1093/eurheartj/ehz767. Eur Heart J. 2020. PMID: 31733058
Triglyceride lowering drugs: not just icosapent ethyl.
Spence JD. Spence JD. Eur Heart J. 2020 Apr 14;41(15):1520. doi: 10.1093/eurheartj/ehaa075. Eur Heart J. 2020. PMID: 32154875 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information